The contribution of absorbed sCD14 on platelets to complement LPS/TLR4 signalling and the subsequent production of proinflammatory products increase our understanding of platelet activation by bacterial products, and may provide a new direction for treatment of patients with bacteraemia/sepsis. This evidence concerns the gene TLR4 and Sepsis.